Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 20 | 2024 | 1986 | 3.100 |
Why?
|
Nanotechnology | 11 | 2012 | 714 | 1.800 |
Why?
|
Drug Carriers | 8 | 2019 | 712 | 1.630 |
Why?
|
Antineoplastic Agents | 22 | 2019 | 13708 | 1.450 |
Why?
|
Neovascularization, Physiologic | 9 | 2012 | 1369 | 1.360 |
Why?
|
Cisplatin | 8 | 2014 | 1661 | 1.280 |
Why?
|
Nanomedicine | 5 | 2019 | 291 | 1.260 |
Why?
|
Drug Delivery Systems | 11 | 2020 | 2238 | 1.240 |
Why?
|
Neoplasms | 24 | 2024 | 22386 | 1.230 |
Why?
|
Hepatocyte Growth Factor | 6 | 2010 | 270 | 1.170 |
Why?
|
Nanotubes | 3 | 2024 | 83 | 1.140 |
Why?
|
Drug Design | 4 | 2019 | 1050 | 1.080 |
Why?
|
Neovascularization, Pathologic | 8 | 2010 | 2643 | 0.950 |
Why?
|
Cell Communication | 3 | 2021 | 1662 | 0.810 |
Why?
|
Cell Line, Tumor | 27 | 2024 | 17149 | 0.750 |
Why?
|
Bone Cements | 1 | 2022 | 326 | 0.720 |
Why?
|
Enzyme Inhibitors | 6 | 2019 | 3734 | 0.720 |
Why?
|
Coculture Techniques | 4 | 2020 | 1343 | 0.720 |
Why?
|
Nanocapsules | 2 | 2013 | 95 | 0.690 |
Why?
|
Transcytosis | 1 | 2019 | 45 | 0.660 |
Why?
|
Nanotubes, Carbon | 2 | 2010 | 72 | 0.650 |
Why?
|
Mice, Inbred BALB C | 14 | 2020 | 6241 | 0.650 |
Why?
|
Endothelial Cells | 7 | 2020 | 3586 | 0.650 |
Why?
|
Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.640 |
Why?
|
Cytotoxins | 1 | 2019 | 154 | 0.640 |
Why?
|
Glucosephosphate Dehydrogenase | 1 | 2019 | 209 | 0.600 |
Why?
|
Propionibacterium acnes | 1 | 2018 | 59 | 0.600 |
Why?
|
Angiogenesis Inducing Agents | 3 | 2011 | 254 | 0.590 |
Why?
|
Nanospheres | 2 | 2014 | 21 | 0.570 |
Why?
|
Neoplasm Proteins | 5 | 2021 | 3611 | 0.550 |
Why?
|
Polyethylene Glycols | 3 | 2013 | 1195 | 0.550 |
Why?
|
Doxorubicin | 5 | 2010 | 2229 | 0.550 |
Why?
|
Immunoconjugates | 2 | 2024 | 968 | 0.520 |
Why?
|
Monitoring, Immunologic | 1 | 2016 | 100 | 0.510 |
Why?
|
Immunotherapy | 2 | 2024 | 4728 | 0.490 |
Why?
|
Carcinoma, Lewis Lung | 3 | 2012 | 108 | 0.470 |
Why?
|
Mice | 33 | 2024 | 82045 | 0.460 |
Why?
|
Angiogenesis Inhibitors | 4 | 2005 | 2062 | 0.460 |
Why?
|
Liposomes | 4 | 2016 | 792 | 0.460 |
Why?
|
Platinum | 2 | 2012 | 222 | 0.440 |
Why?
|
Embryonic Stem Cells | 2 | 2012 | 1249 | 0.440 |
Why?
|
Endothelium, Vascular | 8 | 2021 | 4425 | 0.440 |
Why?
|
Mammary Neoplasms, Animal | 1 | 2014 | 123 | 0.440 |
Why?
|
Leukocytes | 1 | 2021 | 2030 | 0.440 |
Why?
|
Animals | 43 | 2024 | 169418 | 0.430 |
Why?
|
Fullerenes | 2 | 2010 | 14 | 0.430 |
Why?
|
Insulin-Like Growth Factor II | 2 | 2012 | 268 | 0.430 |
Why?
|
Polymers | 4 | 2016 | 1631 | 0.410 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5342 | 0.410 |
Why?
|
Receptors, Purinergic P2Y12 | 1 | 2013 | 115 | 0.410 |
Why?
|
Acne Vulgaris | 1 | 2018 | 351 | 0.410 |
Why?
|
Antibodies | 2 | 2019 | 2425 | 0.400 |
Why?
|
Mitochondria | 2 | 2024 | 3672 | 0.390 |
Why?
|
Glycomics | 2 | 2011 | 118 | 0.390 |
Why?
|
Cell Survival | 11 | 2021 | 5801 | 0.380 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7471 | 0.380 |
Why?
|
Chromones | 2 | 2009 | 148 | 0.370 |
Why?
|
Melanoma, Experimental | 3 | 2009 | 561 | 0.360 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1660 | 0.360 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2013 | 284 | 0.360 |
Why?
|
Organoplatinum Compounds | 1 | 2012 | 408 | 0.350 |
Why?
|
Proto-Oncogene Proteins c-akt | 5 | 2013 | 2465 | 0.340 |
Why?
|
Ticlopidine | 1 | 2014 | 730 | 0.340 |
Why?
|
Molecular Structure | 4 | 2019 | 1889 | 0.340 |
Why?
|
Drug Monitoring | 1 | 2016 | 964 | 0.340 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 720 | 0.340 |
Why?
|
Cancer Vaccines | 1 | 2017 | 1044 | 0.330 |
Why?
|
Heparitin Sulfate | 1 | 2011 | 224 | 0.330 |
Why?
|
Xenograft Model Antitumor Assays | 4 | 2024 | 3619 | 0.320 |
Why?
|
Anti-Inflammatory Agents | 1 | 2018 | 1816 | 0.300 |
Why?
|
Molecular Targeted Therapy | 4 | 2020 | 2834 | 0.300 |
Why?
|
Anticarcinogenic Agents | 1 | 2009 | 251 | 0.290 |
Why?
|
Models, Theoretical | 2 | 2019 | 3590 | 0.290 |
Why?
|
Morpholines | 2 | 2009 | 583 | 0.290 |
Why?
|
Neoplasms, Experimental | 1 | 2013 | 1232 | 0.290 |
Why?
|
Microsatellite Repeats | 2 | 2007 | 784 | 0.290 |
Why?
|
Glucose | 1 | 2019 | 4355 | 0.290 |
Why?
|
Leukoplakia | 1 | 2007 | 18 | 0.280 |
Why?
|
Protein Processing, Post-Translational | 2 | 2021 | 1969 | 0.280 |
Why?
|
Protein Engineering | 3 | 2019 | 549 | 0.270 |
Why?
|
MutS Homolog 2 Protein | 1 | 2007 | 200 | 0.270 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2012 | 3520 | 0.260 |
Why?
|
Breast Neoplasms | 8 | 2021 | 21156 | 0.260 |
Why?
|
Signal Transduction | 11 | 2016 | 23638 | 0.250 |
Why?
|
Neoplasm Metastasis | 5 | 2021 | 4931 | 0.250 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5426 | 0.250 |
Why?
|
Tissue Engineering | 2 | 2015 | 1890 | 0.250 |
Why?
|
Cholesterol | 3 | 2020 | 2910 | 0.250 |
Why?
|
Medical Oncology | 1 | 2017 | 2347 | 0.250 |
Why?
|
Extracellular Matrix | 2 | 2011 | 1738 | 0.240 |
Why?
|
Molecular Dynamics Simulation | 2 | 2019 | 434 | 0.240 |
Why?
|
Ginsenosides | 1 | 2004 | 12 | 0.240 |
Why?
|
Fibroblast Growth Factors | 1 | 2011 | 873 | 0.240 |
Why?
|
Panax | 1 | 2004 | 28 | 0.240 |
Why?
|
Cells, Cultured | 10 | 2018 | 19041 | 0.230 |
Why?
|
Permeability | 2 | 2018 | 725 | 0.230 |
Why?
|
MAP Kinase Signaling System | 2 | 2009 | 1489 | 0.230 |
Why?
|
Insulin-Like Growth Factor I | 1 | 2012 | 1943 | 0.230 |
Why?
|
Oncogenes | 1 | 2009 | 1235 | 0.220 |
Why?
|
Thymidine Phosphorylase | 1 | 2003 | 15 | 0.220 |
Why?
|
Mice, Inbred C57BL | 6 | 2024 | 22365 | 0.220 |
Why?
|
Models, Molecular | 4 | 2019 | 5443 | 0.220 |
Why?
|
Macrophages | 1 | 2018 | 5797 | 0.210 |
Why?
|
Isoenzymes | 2 | 2005 | 1685 | 0.200 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2768 | 0.200 |
Why?
|
Chitosan | 1 | 2024 | 141 | 0.200 |
Why?
|
Phytotherapy | 1 | 2004 | 298 | 0.200 |
Why?
|
Drug Discovery | 1 | 2010 | 1062 | 0.200 |
Why?
|
Macromolecular Substances | 2 | 2018 | 1435 | 0.200 |
Why?
|
Humans | 54 | 2024 | 768451 | 0.190 |
Why?
|
Cyclooxygenase Inhibitors | 1 | 2003 | 361 | 0.190 |
Why?
|
Mitogen-Activated Protein Kinases | 2 | 2003 | 1246 | 0.190 |
Why?
|
Polyenes | 2 | 2012 | 68 | 0.190 |
Why?
|
Epithelial-Mesenchymal Transition | 2 | 2016 | 757 | 0.190 |
Why?
|
Peptides | 1 | 2013 | 4368 | 0.180 |
Why?
|
Umbilical Veins | 3 | 2009 | 425 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 2 | 2015 | 5709 | 0.180 |
Why?
|
Mammary Neoplasms, Experimental | 2 | 2013 | 507 | 0.180 |
Why?
|
Inhibitory Concentration 50 | 2 | 2012 | 467 | 0.180 |
Why?
|
Endothelial Growth Factors | 1 | 2003 | 674 | 0.170 |
Why?
|
DNA Glycosylases | 1 | 2021 | 125 | 0.170 |
Why?
|
Kidney | 2 | 2012 | 7064 | 0.170 |
Why?
|
Lymphokines | 1 | 2003 | 927 | 0.170 |
Why?
|
rho GTP-Binding Proteins | 1 | 2021 | 279 | 0.170 |
Why?
|
Alginates | 1 | 2021 | 250 | 0.170 |
Why?
|
Disease Models, Animal | 5 | 2024 | 18388 | 0.170 |
Why?
|
Chemical Phenomena | 1 | 2019 | 486 | 0.170 |
Why?
|
Insulin Resistance | 1 | 2013 | 3974 | 0.170 |
Why?
|
Lung Neoplasms | 1 | 2024 | 13589 | 0.170 |
Why?
|
Drug Stability | 1 | 2019 | 291 | 0.160 |
Why?
|
Tumor Cells, Cultured | 5 | 2021 | 6135 | 0.160 |
Why?
|
Microtechnology | 1 | 2019 | 70 | 0.160 |
Why?
|
Algorithms | 2 | 2016 | 14158 | 0.150 |
Why?
|
Vesicular Transport Proteins | 1 | 2021 | 377 | 0.150 |
Why?
|
Deoxycytidine | 2 | 2013 | 888 | 0.150 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 1 | 2019 | 397 | 0.150 |
Why?
|
Carrier Proteins | 2 | 2012 | 4948 | 0.150 |
Why?
|
Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2018 | 114 | 0.150 |
Why?
|
Biofilms | 1 | 2022 | 634 | 0.150 |
Why?
|
Models, Biological | 4 | 2016 | 9505 | 0.150 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 2018 | 187 | 0.150 |
Why?
|
Cytoskeleton | 2 | 2021 | 1179 | 0.150 |
Why?
|
Stem Cells | 1 | 2011 | 3538 | 0.150 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2020 | 423 | 0.150 |
Why?
|
Antibody Specificity | 1 | 2019 | 1065 | 0.140 |
Why?
|
DNA Gyrase | 1 | 2018 | 86 | 0.140 |
Why?
|
Phenotype | 6 | 2021 | 16712 | 0.140 |
Why?
|
Apoptosis | 6 | 2016 | 9526 | 0.140 |
Why?
|
Phosphorylation | 5 | 2009 | 8332 | 0.140 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2007 | 4083 | 0.140 |
Why?
|
Tissue Distribution | 3 | 2016 | 2298 | 0.140 |
Why?
|
Shear Strength | 1 | 2016 | 161 | 0.130 |
Why?
|
Head and Neck Neoplasms | 3 | 2007 | 2915 | 0.130 |
Why?
|
Esterases | 1 | 2016 | 89 | 0.130 |
Why?
|
Nitric Oxide | 1 | 2005 | 2146 | 0.130 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2020 | 446 | 0.130 |
Why?
|
Melanoma | 3 | 2009 | 5740 | 0.130 |
Why?
|
Administration, Topical | 1 | 2018 | 707 | 0.130 |
Why?
|
Mitochondrial Proteins | 1 | 2021 | 979 | 0.130 |
Why?
|
Prostheses and Implants | 1 | 2022 | 1279 | 0.130 |
Why?
|
Immunity | 1 | 2021 | 1002 | 0.130 |
Why?
|
Substrate Specificity | 1 | 2019 | 1775 | 0.130 |
Why?
|
Promoter Regions, Genetic | 1 | 2007 | 5803 | 0.130 |
Why?
|
Bibenzyls | 2 | 2005 | 11 | 0.120 |
Why?
|
Artificial Intelligence | 1 | 2010 | 2659 | 0.120 |
Why?
|
Gene Expression Profiling | 3 | 2015 | 9507 | 0.120 |
Why?
|
Hydrogels | 1 | 2021 | 745 | 0.120 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2013 | 699 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2020 | 3939 | 0.120 |
Why?
|
Rats | 3 | 2022 | 23839 | 0.120 |
Why?
|
NG-Nitroarginine Methyl Ester | 2 | 2005 | 262 | 0.120 |
Why?
|
Pyridines | 2 | 2004 | 2888 | 0.120 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11843 | 0.120 |
Why?
|
Cell Membrane | 2 | 2016 | 3664 | 0.110 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2013 | 2884 | 0.110 |
Why?
|
Treatment Outcome | 7 | 2018 | 65409 | 0.110 |
Why?
|
Stilbenes | 2 | 2005 | 155 | 0.110 |
Why?
|
Drug Evaluation, Preclinical | 2 | 2019 | 1339 | 0.110 |
Why?
|
Membrane Microdomains | 1 | 2015 | 205 | 0.110 |
Why?
|
Zebrafish | 3 | 2010 | 3038 | 0.110 |
Why?
|
Caspase 3 | 1 | 2016 | 732 | 0.110 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2003 | 2279 | 0.110 |
Why?
|
Proto-Oncogene Proteins | 2 | 2003 | 4534 | 0.110 |
Why?
|
Keratinocytes | 1 | 2018 | 879 | 0.110 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2016 | 548 | 0.110 |
Why?
|
Flavonoids | 2 | 2009 | 447 | 0.110 |
Why?
|
High-Throughput Screening Assays | 1 | 2019 | 940 | 0.110 |
Why?
|
Mice, Nude | 1 | 2019 | 3635 | 0.110 |
Why?
|
Ascorbic Acid | 1 | 2016 | 658 | 0.100 |
Why?
|
Tumor Burden | 2 | 2016 | 1909 | 0.100 |
Why?
|
Biocompatible Materials | 1 | 2021 | 1703 | 0.100 |
Why?
|
Ligands | 1 | 2019 | 3281 | 0.100 |
Why?
|
DNA Methylation | 1 | 2007 | 4421 | 0.100 |
Why?
|
Podophyllotoxin | 1 | 2012 | 20 | 0.100 |
Why?
|
Maleates | 1 | 2012 | 18 | 0.100 |
Why?
|
Receptor, IGF Type 2 | 1 | 2012 | 35 | 0.100 |
Why?
|
Nuclear Proteins | 1 | 2007 | 5808 | 0.100 |
Why?
|
Antimetabolites, Antineoplastic | 2 | 2013 | 647 | 0.100 |
Why?
|
Receptors, Immunologic | 1 | 2018 | 1415 | 0.100 |
Why?
|
Adjuvants, Immunologic | 1 | 2017 | 998 | 0.100 |
Why?
|
Glucosamine | 1 | 2012 | 128 | 0.100 |
Why?
|
Succinic Acid | 1 | 2012 | 86 | 0.100 |
Why?
|
Embryoid Bodies | 1 | 2012 | 65 | 0.100 |
Why?
|
Structure-Activity Relationship | 2 | 2010 | 3073 | 0.100 |
Why?
|
Cell Division | 3 | 2003 | 4479 | 0.100 |
Why?
|
Heparan Sulfate Proteoglycans | 2 | 2009 | 112 | 0.100 |
Why?
|
Stress, Mechanical | 1 | 2016 | 1680 | 0.090 |
Why?
|
Taxoids | 1 | 2015 | 669 | 0.090 |
Why?
|
DNA Repair | 1 | 2021 | 2051 | 0.090 |
Why?
|
Receptors, Notch | 1 | 2016 | 752 | 0.090 |
Why?
|
Killer Cells, Natural | 1 | 2020 | 2209 | 0.090 |
Why?
|
Nanostructures | 1 | 2016 | 553 | 0.090 |
Why?
|
Molecular Weight | 1 | 2013 | 2173 | 0.090 |
Why?
|
Paclitaxel | 2 | 2016 | 1737 | 0.090 |
Why?
|
Adenocarcinoma | 1 | 2009 | 6400 | 0.090 |
Why?
|
Cell Line | 2 | 2018 | 15609 | 0.090 |
Why?
|
Phthalazines | 2 | 2004 | 396 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 3637 | 0.090 |
Why?
|
Binding Sites | 1 | 2019 | 6030 | 0.090 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2024 | 4642 | 0.090 |
Why?
|
Extracellular Matrix Proteins | 1 | 2015 | 835 | 0.090 |
Why?
|
Base Sequence | 1 | 2021 | 12428 | 0.090 |
Why?
|
Oligopeptides | 1 | 2016 | 1193 | 0.090 |
Why?
|
Quantitative Structure-Activity Relationship | 1 | 2010 | 28 | 0.090 |
Why?
|
Drug Resistance, Bacterial | 1 | 2018 | 1064 | 0.090 |
Why?
|
Microscopy, Electron, Scanning | 2 | 2015 | 946 | 0.090 |
Why?
|
Models, Chemical | 1 | 2012 | 611 | 0.090 |
Why?
|
Protein Stability | 1 | 2012 | 584 | 0.090 |
Why?
|
Hydroxides | 1 | 2009 | 46 | 0.080 |
Why?
|
Flow Cytometry | 2 | 2011 | 5904 | 0.080 |
Why?
|
Receptor, IGF Type 1 | 1 | 2012 | 384 | 0.080 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 617 | 0.080 |
Why?
|
Endothelium | 1 | 2012 | 768 | 0.080 |
Why?
|
Protein Structure, Quaternary | 1 | 2010 | 429 | 0.080 |
Why?
|
Cell Adhesion | 1 | 2015 | 3103 | 0.080 |
Why?
|
Cell Differentiation | 3 | 2012 | 11674 | 0.080 |
Why?
|
Sulfotransferases | 1 | 2009 | 150 | 0.080 |
Why?
|
Chromatin | 1 | 2021 | 2969 | 0.080 |
Why?
|
Gene Expression Regulation, Developmental | 2 | 2011 | 3612 | 0.080 |
Why?
|
Microscopy, Fluorescence | 1 | 2016 | 2640 | 0.080 |
Why?
|
Mesoderm | 1 | 2012 | 679 | 0.080 |
Why?
|
Crystallization | 1 | 2009 | 531 | 0.080 |
Why?
|
Drug Compounding | 1 | 2009 | 243 | 0.080 |
Why?
|
Glycocalyx | 1 | 2009 | 98 | 0.080 |
Why?
|
Male | 14 | 2018 | 364781 | 0.080 |
Why?
|
Molecular Conformation | 1 | 2009 | 542 | 0.080 |
Why?
|
Monocytes | 1 | 2018 | 2591 | 0.080 |
Why?
|
Clinical Trials as Topic | 2 | 2017 | 8051 | 0.080 |
Why?
|
Female | 13 | 2024 | 396943 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2150 | 0.080 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 621 | 0.070 |
Why?
|
Rats, Sprague-Dawley | 2 | 2018 | 8201 | 0.070 |
Why?
|
Fluorescent Dyes | 1 | 2016 | 1924 | 0.070 |
Why?
|
Interleukin-6 | 1 | 2018 | 3234 | 0.070 |
Why?
|
Solubility | 1 | 2009 | 1086 | 0.070 |
Why?
|
Regenerative Medicine | 1 | 2011 | 311 | 0.070 |
Why?
|
Carboplatin | 1 | 2010 | 798 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2019 | 3697 | 0.070 |
Why?
|
Transfection | 3 | 2006 | 5767 | 0.070 |
Why?
|
Neoplastic Stem Cells | 1 | 2015 | 1357 | 0.070 |
Why?
|
Surface Properties | 1 | 2009 | 1168 | 0.070 |
Why?
|
Cell Proliferation | 4 | 2019 | 10494 | 0.070 |
Why?
|
Esophageal Neoplasms | 1 | 2016 | 1676 | 0.070 |
Why?
|
Materials Testing | 1 | 2009 | 871 | 0.060 |
Why?
|
Organ Size | 1 | 2011 | 2268 | 0.060 |
Why?
|
Alternative Splicing | 1 | 2010 | 1094 | 0.060 |
Why?
|
Gene Knockdown Techniques | 1 | 2009 | 1608 | 0.060 |
Why?
|
Spleen | 1 | 2011 | 2298 | 0.060 |
Why?
|
Nitric Oxide Donors | 1 | 2005 | 126 | 0.060 |
Why?
|
Biological Transport | 1 | 2009 | 2089 | 0.060 |
Why?
|
Korea | 1 | 2004 | 98 | 0.060 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2009 | 2488 | 0.060 |
Why?
|
Endocytosis | 1 | 2009 | 960 | 0.060 |
Why?
|
Surgical Sponges | 1 | 2004 | 40 | 0.060 |
Why?
|
Americas | 1 | 2004 | 110 | 0.060 |
Why?
|
DNA, Neoplasm | 2 | 2007 | 1749 | 0.060 |
Why?
|
Guanylate Cyclase | 1 | 2005 | 206 | 0.060 |
Why?
|
Antigens, CD | 1 | 2015 | 4029 | 0.060 |
Why?
|
Computer Simulation | 1 | 2018 | 6278 | 0.060 |
Why?
|
Skin | 1 | 2018 | 4520 | 0.060 |
Why?
|
Lipoxygenase | 1 | 2003 | 72 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4572 | 0.060 |
Why?
|
Drug Implants | 1 | 2004 | 231 | 0.060 |
Why?
|
Cell Cycle | 2 | 2009 | 2942 | 0.060 |
Why?
|
DNA Mismatch Repair | 1 | 2007 | 433 | 0.060 |
Why?
|
Deoxyribose | 1 | 2003 | 7 | 0.060 |
Why?
|
Loss of Heterozygosity | 1 | 2006 | 663 | 0.060 |
Why?
|
Cyclooxygenase 1 | 1 | 2003 | 98 | 0.060 |
Why?
|
Ribosemonophosphates | 1 | 2003 | 7 | 0.060 |
Why?
|
Lipoxygenase Inhibitors | 1 | 2003 | 93 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2013 | 10784 | 0.050 |
Why?
|
Spectrometry, Mass, Electrospray Ionization | 1 | 2004 | 267 | 0.050 |
Why?
|
Water | 1 | 2009 | 1421 | 0.050 |
Why?
|
Models, Animal | 1 | 2009 | 2126 | 0.050 |
Why?
|
Breast | 1 | 2012 | 1976 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 318 | 0.050 |
Why?
|
Heme Oxygenase (Decyclizing) | 1 | 2003 | 167 | 0.050 |
Why?
|
Aneuploidy | 1 | 2006 | 572 | 0.050 |
Why?
|
Heparin, Low-Molecular-Weight | 1 | 2004 | 344 | 0.050 |
Why?
|
Stereoisomerism | 1 | 2003 | 612 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2009 | 1625 | 0.050 |
Why?
|
Nitric Oxide Synthase | 1 | 2005 | 911 | 0.050 |
Why?
|
Time Factors | 4 | 2015 | 40271 | 0.050 |
Why?
|
Gene Regulatory Networks | 1 | 2011 | 1755 | 0.050 |
Why?
|
Fluorescence | 1 | 2004 | 760 | 0.050 |
Why?
|
Genomic Instability | 1 | 2006 | 714 | 0.050 |
Why?
|
Laminin | 1 | 2003 | 407 | 0.050 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2003 | 321 | 0.050 |
Why?
|
Aerosols | 1 | 2004 | 637 | 0.050 |
Why?
|
Androstadienes | 1 | 2003 | 348 | 0.050 |
Why?
|
Vascular Endothelial Growth Factors | 1 | 2003 | 750 | 0.050 |
Why?
|
Cyclooxygenase 2 | 1 | 2003 | 599 | 0.050 |
Why?
|
Immunohistochemistry | 2 | 2013 | 11138 | 0.050 |
Why?
|
Mouth Neoplasms | 1 | 2006 | 598 | 0.050 |
Why?
|
Mice, Transgenic | 1 | 2013 | 9558 | 0.050 |
Why?
|
Chalcones | 1 | 2020 | 32 | 0.050 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2003 | 639 | 0.050 |
Why?
|
Invertebrates | 1 | 2021 | 55 | 0.050 |
Why?
|
Particle Size | 2 | 2021 | 1654 | 0.040 |
Why?
|
Biosensing Techniques | 1 | 2007 | 663 | 0.040 |
Why?
|
Heme Oxygenase-1 | 1 | 2003 | 366 | 0.040 |
Why?
|
Genes, Helminth | 1 | 2021 | 146 | 0.040 |
Why?
|
Transcription Initiation Site | 1 | 2021 | 189 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2021 | 20231 | 0.040 |
Why?
|
Kupffer Cells | 1 | 2020 | 143 | 0.040 |
Why?
|
Gene Expression | 1 | 2013 | 7605 | 0.040 |
Why?
|
Biological Assay | 1 | 2003 | 629 | 0.040 |
Why?
|
Propionates | 1 | 2020 | 180 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2007 | 6091 | 0.040 |
Why?
|
Species Specificity | 1 | 2004 | 2422 | 0.040 |
Why?
|
Helminth Proteins | 1 | 2021 | 172 | 0.040 |
Why?
|
Proteoglycans | 1 | 2003 | 807 | 0.040 |
Why?
|
Hepatic Stellate Cells | 1 | 2020 | 117 | 0.040 |
Why?
|
Genes, Homeobox | 1 | 2021 | 289 | 0.040 |
Why?
|
Vertebrates | 1 | 2021 | 227 | 0.040 |
Why?
|
Macrolides | 1 | 2020 | 205 | 0.040 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2003 | 665 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4298 | 0.040 |
Why?
|
Thalidomide | 1 | 2004 | 885 | 0.040 |
Why?
|
Amino Acid Sequence | 1 | 2010 | 13452 | 0.040 |
Why?
|
Protein Binding | 1 | 2011 | 9376 | 0.040 |
Why?
|
China | 1 | 2004 | 2398 | 0.040 |
Why?
|
Acetylation | 1 | 2021 | 1053 | 0.040 |
Why?
|
Blood Coagulation | 1 | 2024 | 1162 | 0.040 |
Why?
|
Molecular Sequence Data | 1 | 2010 | 17647 | 0.040 |
Why?
|
Drug Combinations | 1 | 2003 | 2079 | 0.030 |
Why?
|
Heparin | 1 | 2004 | 1636 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2003 | 3594 | 0.030 |
Why?
|
Cytoplasm | 1 | 2021 | 1503 | 0.030 |
Why?
|
Diagnostic Imaging | 1 | 2011 | 3543 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2021 | 2751 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2021 | 2184 | 0.030 |
Why?
|
Membrane Proteins | 2 | 2003 | 7895 | 0.030 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2007 | 2910 | 0.030 |
Why?
|
Lysine | 1 | 2021 | 989 | 0.030 |
Why?
|
Catalase | 1 | 2016 | 219 | 0.030 |
Why?
|
Microfluidics | 1 | 2021 | 675 | 0.030 |
Why?
|
Cytokines | 1 | 2011 | 7449 | 0.030 |
Why?
|
Mice, Knockout | 1 | 2011 | 14480 | 0.030 |
Why?
|
Drug Therapy, Combination | 1 | 2005 | 6320 | 0.030 |
Why?
|
Cell Count | 1 | 2019 | 1835 | 0.030 |
Why?
|
Collagen | 1 | 2003 | 2646 | 0.030 |
Why?
|
Cell Cycle Proteins | 1 | 2006 | 3463 | 0.030 |
Why?
|
Pancreatic Neoplasms | 1 | 2012 | 5442 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2021 | 2232 | 0.030 |
Why?
|
Mesenchymal Stem Cells | 1 | 2024 | 1671 | 0.030 |
Why?
|
Swine | 1 | 2024 | 5996 | 0.030 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2010 | 8635 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1669 | 0.030 |
Why?
|
Hepatocytes | 1 | 2020 | 1247 | 0.030 |
Why?
|
Blood Platelets | 1 | 2024 | 2485 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2003 | 6527 | 0.030 |
Why?
|
Hydrogen Peroxide | 1 | 2016 | 742 | 0.030 |
Why?
|
Evolution, Molecular | 1 | 2021 | 1897 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2021 | 2889 | 0.020 |
Why?
|
Necrosis | 1 | 2016 | 1621 | 0.020 |
Why?
|
Hemorrhage | 1 | 2024 | 3458 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2021 | 4294 | 0.020 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 998 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2012 | 408 | 0.020 |
Why?
|
Cell Death | 1 | 2016 | 1684 | 0.020 |
Why?
|
Proteome | 1 | 2021 | 1881 | 0.020 |
Why?
|
Drug Synergism | 1 | 2013 | 1765 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1197 | 0.020 |
Why?
|
Antioxidants | 1 | 2016 | 1678 | 0.020 |
Why?
|
Anticoagulants | 1 | 2024 | 4840 | 0.020 |
Why?
|
Lactic Acid | 1 | 2012 | 1140 | 0.020 |
Why?
|
DNA Mutational Analysis | 1 | 2015 | 4120 | 0.020 |
Why?
|
Cyclin B1 | 1 | 2006 | 57 | 0.020 |
Why?
|
Cyclin B | 1 | 2006 | 104 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2015 | 6242 | 0.020 |
Why?
|
Mitotic Index | 1 | 2006 | 164 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2003 | 11930 | 0.020 |
Why?
|
Lung | 1 | 2004 | 10090 | 0.020 |
Why?
|
Chromosomal Instability | 1 | 2006 | 178 | 0.020 |
Why?
|
Ubiquitin-Protein Ligase Complexes | 1 | 2006 | 170 | 0.020 |
Why?
|
Liver | 1 | 2020 | 7575 | 0.010 |
Why?
|
Absorption | 1 | 2004 | 243 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 42623 | 0.010 |
Why?
|
Biological Availability | 1 | 2004 | 390 | 0.010 |
Why?
|
Immunoblotting | 1 | 2006 | 1650 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 2477 | 0.010 |
Why?
|
Emphysema | 1 | 2004 | 238 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2007 | 59680 | 0.010 |
Why?
|
Administration, Inhalation | 1 | 2004 | 1170 | 0.010 |
Why?
|
Mitosis | 1 | 2006 | 1191 | 0.010 |
Why?
|
Inflammation | 1 | 2020 | 10865 | 0.010 |
Why?
|
India | 1 | 2006 | 2323 | 0.010 |
Why?
|
Child | 1 | 2007 | 80863 | 0.010 |
Why?
|
Adolescent | 1 | 2007 | 89168 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 15460 | 0.010 |
Why?
|
Rabbits | 1 | 2004 | 4786 | 0.010 |
Why?
|
Phagocytosis | 1 | 2003 | 1531 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2003 | 2096 | 0.010 |
Why?
|
Mutation | 1 | 2021 | 30243 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3794 | 0.010 |
Why?
|
Aged | 1 | 2007 | 171520 | 0.010 |
Why?
|
Middle Aged | 1 | 2007 | 223418 | 0.010 |
Why?
|
Adult | 1 | 2007 | 223542 | 0.010 |
Why?
|
Thrombosis | 1 | 2004 | 2956 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2003 | 7599 | 0.010 |
Why?
|
Proteins | 1 | 2003 | 6008 | 0.000 |
Why?
|
RNA, Messenger | 1 | 2003 | 12813 | 0.000 |
Why?
|